Eventide Asset Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $21.6M | Sell |
|
|||||
|
2022
Q4 | $65.6M | Sell |
|
|||||
|
2022
Q3 | $30M | Hold |
|
|||||
|
2022
Q2 | $21M | Hold |
|
|||||
|
2022
Q1 | $29.6M | Buy |
|
|||||
|
2021
Q4 | $42.2M | Hold |
|
|||||
|
2021
Q3 | $43M | Buy |
|
|||||
|
2021
Q2 | $35.6M | Buy |
|
|||||
|
2021
Q1 | $39.7M | Buy |
|
|||||
|
2020
Q4 | $43M | Hold |
|
|||||
|
2020
Q3 | $32.8M | Buy |
|
|||||
|
2020
Q2 | $15.2M | Buy |
|